TROY, Mich., June 11 /PRNewswire/ -- Delphi Corp. continues its transformation into new markets. Delphi Medical Systems Corp., a subsidiary of Delphi, will introduce its technologies, service offerings and business strategy to potential customers at Medical Design & Manufacturing East (MD&M) in New York City from June 15-17.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020315/DEF002LOGO )
MD&M represents Delphi Medical Systems’ first major medical trade show, and is the largest event for medical device manufacturing in the world.
Delphi Medical Systems representatives will be available to discuss their strategy to focus on dialysis, infusion, mobility, respiratory care, and vital signs monitoring at booth number 2173.
“We are excited about attending MD&M this year and reaching out to prospective customers who may not yet know us,” said Christophe Sevrain, managing director of Delphi Medical Systems Corporation. “Delphi Medical Systems is prepared to leverage Delphi’s history of success in innovative technologies to help bring new standards in quality, reliability and innovation to a global market well into the future.”
As a Delphi subsidiary, Delphi Medical Systems has access to Delphi’s technology experience and strength, as well as the global footprint needed to supply medical devices virtually anywhere in the world, focusing in the following areas:
* Dialysis - As more people become candidates for dialysis, and quality of life issues become increasingly important, dialysis technology must continually reach new levels. With core competencies in fluid handling, thermal management, electronic controls, sensor technologies, and others, Delphi Medical Systems can help deliver improved treatment customization, efficiency and clinical effectiveness for dialysis manufacturers and patients.
* Infusion - From hospitals to homecare, a new generation of intravenous infusion devices is broadening market opportunities while improving patient satisfaction. Delphi’s technologies, including micro-electro-mechanical systems, power management, wireless communications, and electronic controls can be used in traditional and non-traditional therapies.
* Mobility - In order to improve the quality of life for power wheelchair consumers -- from increased independence to comfort in design and support in performance -- innovations in power mobility are reaching unprecedented heights. Delphi Medical Systems can bring new features in comfort, convenience and electronics integration to this market.
* Respiratory Care - Respiratory care equipment is moving into a variety of new and different settings. With access to decades of experience in bringing complex systems to market, Delphi Medical Systems is ready to improve CPAP/BiPAP systems, ventilators and spirometers through electronic controls, gas flow management, power and thermal management, wireless technologies, and precision molding capabilities.
* Vital Signs Monitoring - Delphi’s experience in providing high-value, small and more portable technology, ergonomic design, and remote connectivity can help monitoring systems manufacturers and distributors offer the opportunity to improve the quality of life for many patients. Delphi’s core competencies include wireless technologies, electronic controls, human interface technologies, and power management.
Capable of providing the technology building blocks to address challenges in a global market, Delphi Medical Systems recently announced an $80 million contract with Sunrise Medical, one of the world’s largest manufacturers of homecare and extended care products.
For more information on Delphi, please visit its media room at: http:///www.delphi.com/media .
Forward Looking Statement
All statements contained or incorporated in this press release which address operating performance, events or developments that we expect or anticipate may occur in the future (including statements relating to future sales, cash flow or earnings expectations, savings expected as a result of our global restructurings or other initiatives, portfolio restructuring plans, volume growth, awarded sales contracts and customer diversification expectations or statements expressing general optimism about future operating results) are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are made on the basis of management’s current views and assumptions with respect to future events. Important factors, risks and uncertainties which may cause actual results to differ from those expressed in our forward-looking statements are discussed in detail in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31, 2003. In particular, the achievement of projected levels of revenue, earnings, cash flow and debt levels will depend on our ability to execute our portfolio and other global restructuring plans in a manner which satisfactorily addresses any resultant antitrust or labor issues and customer concerns, any contingent liabilities related to divestitures or integration costs associated with acquisitions, and other matters; our continued ability to diversify our customer base and still maintain existing GM business; the continued protection and exploitation of our intellectual property to develop new products and enter new markets; and our ability to capture expected benefits of our cost reduction initiatives so as to maintain flexibility to respond to adverse and cyclical changes in general economic conditions and in the automotive industry in each market we operate, including customer cost reduction initiatives, potential increases in warranty costs, pension contributions, healthcare costs, disruptions in the labor, commodities or transportation markets caused by terrorism or war and other changes in the political and regulatory environments where we do business. Delphi does not intend or assume any obligation to update any of these forward-looking statements.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020315/DEF002LOGOPRN Photo Desk, photodesk@prnewswire.comDelphi Corporation
CONTACT: Luce Rubio of Delphi Corp., +1-248-813-2618
Web site: http://www.delphi.com/media
Company News On-Call: http://www.prnewswire.com/comp/076666.html
